Sign In
Upcoming Event
Free Newsletter
B. Braun Medical Inc.'s - Medical Device Manufacturing Plant PHOTO/FILE
B. Braun receives clearance for new catheter product
Stacy Wescoe//September 25, 2024//
Listen to this articleGood news for a Bethlehem manufacturer of health care technology.
Braun Medical Inc. said that the U.S. Food and Drug Administration has granted 510(k) clearance for the Introcan Safety 2 Deep Access IV Catheter, the newest addition to the company’s Introcan Safety 2 IV Catheter portfolio.
According to the manufacturer, the Introcan Safety 2 Deep Access IV Catheter merges the existing technologies of the original Introcan Safety 2 Multi-Access and Introcan Safety Deep Access Catheters, offering clinicians an advanced solution that combines the strengths of both devices.
In a press release, B. Braun said the catheter provides fully automatic passive safety needlestick protection and multi-access blood control in longer lengths and is designed to access deeper veins in patients with difficult vascular access and to achieve longer dwell times.
The company said new catheter has been shown to significantly increase PIVC dwell times to approximately 5.7 days — compared to 3.8 days for standard long PIVCs — to help reduce PIVC restarts and help reduce escalation to more costly, invasive devices such as peripherally inserted central catheters (PICC).
“We are excited to broaden our Introcan Safety 2 IV Catheter portfolio, allowing our customers to benefit from passive safety and blood exposure protection with deep access technology,” said Chad Laity, director of marketing, Vascular Access, IV Systems and Securement. “By offering a reliable solution for challenging cases, we aim to help improve patient outcomes and reduce the need for more complex procedures.”
